We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: NO FURTHER ACTION EXPECTED ON TAXUS RECALL
FDA: NO FURTHER ACTION EXPECTED ON TAXUS RECALL
October 15, 2004
Center for Devices and Radiological Health Director Daniel Schultz confirmed last week that the FDA doesn’t anticipate taking any regulatory action against Boston Scientific in connection with firm’s recall of approximately 100,000 Taxus drug-eluting stents.